GENTAMICIN
Generic: GENTAMICIN
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
GENTAMICIN SULFATEActive Substance
1980-06-05Original Approval
GENTAMICIN is FDA application ANDA062251, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2014-11-12
GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APP PharmaceuticalDefective Container: Vials may be missing stoppers.
Class II2013-05-02
Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Presence of Particulate Matter: visible particles were identified floating in the primary container.
Class II2025-05-29
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India foFailed Stability Specifications: Out of specification results for the Color Absorbance test during
Top Reported Reactions
1
DRUG INEFFECTIVE
1,298 reports
2
ACUTE KIDNEY INJURY
1,218 reports
3
PYREXIA
902 reports
4
OFF LABEL USE
889 reports
5
RENAL FAILURE
722 reports
6
DIARRHOEA
573 reports
7
CONDITION AGGRAVATED
514 reports
8
SEPSIS
509 reports
9
HYPOTENSION
498 reports
10
NAUSEA
488 reports